secwatch.observer — SEC 8-K summary
======================================

Issuer:     ILLUMINA, INC. (ILMN)
CIK:        0001110803
Form:       8-K
Filed at:   2025-10-30T23:59:59+00:00
Accession:  0001110803-25-000071
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Illumina Q3 revenue $1.08B flat YoY, non-GAAP EPS $1.34 beats; raises FY EPS guidance to $4.65-$4.75
--------------------------------------------------------------------------------

- Q3 GAAP diluted EPS $0.98, non-GAAP diluted EPS $1.34; non-GAAP operating margin 24.5%.
- Revenue $1.08B flat YoY on reported and constant currency; returned to growth ex-China.
- FY2025 guidance raised: revenue decline narrowed to (1.5%)-(0.5%), non-GAAP EPS to $4.65-$4.75 from $4.45-$4.55.
- Repurchased 1.2M shares for $120M at avg $97.10; cash flow from ops $284M, free cash flow $253M.
- Launched new products: 5-base solution, Constellation mapped read tech, BioInsight, and Illumina Protein Prep.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1110803/000111080325000071/0001110803-25-000071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1110803/000111080325000071/ilmn-20251030.htm
  HTML page:      https://secwatch.observer/filing/0001110803-25-000071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer